Apolipoprotein A-I (Serum (s))

Testcode:	E_APOA1
Specimens:	1 ml Serum (s)
Preanalytics/Notes:	Blood sampling after 12 h of fasting
Method:	Nephelometry
Dimension:	g/l
Set-up:	Mon Tue Wed Thu Fri Sat Sun
Duration:	1 day
Indication/Significance:	Differential diagnosis of hyper- and dyslipoproteinaemia Risk assessment and early recognition of the atherogenic risk as well as follow up under hyperlipidemia therapy
Interpretation:	General information more… General information multiple agents and conditions (e. g. estrogens, androgens, diuretics, phenobarbital, phenytoin, prednisolone, pregnancy, smoking, moderate alcohol consumption,weight loss in overweight persons and physical work, acute myocardial infarction or cardiac catheter examinations) can lead to an APO A-1 increase. Androgens, thiazide diuretics, nikotin abusus, carbohydrate rich diet, acute myocardial infarktion or cardiac cath can lead to decreased APO A-I results. Increased results: Familial hyper-alpha-lipoproteinaemia Decreased results: Alpha-lipoprotein deficiency (Tangier disease) apolipoprotein C-II deficiency apolipoprotein A-I Milano diabetes mellitus nephrotic syndrome cholestasis chronic renal failure different forms of hypertriglyceridaemia chronic hepatitis close
Further tests:	Subtyping of apolipoprotein A and apolipoprotein B, see www.bioscientia-humangenetik.de

male
	0,90 - 1,70 g/l

female
	1,08 - 1,85 g/l